NCT00674765

Seroquel for Frequent, Heavy Drinkers

A Phase II Double-blind, Placebo-controlled Trial of Quetiapine for Frequent, Heavy Drinkers (Seroquel2)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 156 (actual)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to examine the effects of quetiapine in reducing percent heavy drinking days and increasing percent abstinent days in alcohol dependent patients who are frequent heavy drinkers.

Detailed description

This trial is a phase 2, randomized, double-blind, placebo-controlled, parallel group trial intended to assess the efficacy of quetiapine compared to placebo in alcoholics who are frequent heavy drinkers.

Conditions

• Alcoholism

Interventions

Type	Name	Description
DRUG	Seroquel	400 mg/day
DRUG	Placebo	400 mg/day

Timeline

• Start date: 2008-01-01
• Primary completion: 2013-01-01
• Completion: 2014-01-01
• First posted: 2008-05-08
• Last updated: 2014-09-17
• Results posted: 2014-09-17

Locations

1 site across 1 country: United States